 |
AbbVie
ABBV
|
267 |
$ 223.98 |
-0.53 % |
$ 396 B |
USA |
 |
Alpine Immune Sciences
ALPN
|
154 |
- |
- |
$ 2.17 B |
USA |
 |
Arbutus Biopharma Corporation
ABUS
|
31.5 |
$ 4.67 |
1.74 % |
$ 775 M |
Canada |
 |
Aclaris Therapeutics
ACRS
|
6.01 |
$ 3.36 |
2.75 % |
$ 260 M |
USA |
 |
Acasti Pharma
ACST
|
1.97 |
- |
4.01 % |
$ 150 M |
Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
25 |
- |
-15.15 % |
$ 60.3 M |
Britain |
 |
Aeglea BioTherapeutics
AGLE
|
216 |
- |
- |
$ 1.01 B |
USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 |
- |
- |
$ 40.3 B |
USA |
 |
Albireo Pharma
ALBO
|
14.7 |
- |
-0.23 % |
$ 916 M |
USA |
 |
Ascendis Pharma A/S
ASND
|
132 |
$ 210.16 |
4.43 % |
$ 5 B |
Danmark |
 |
Ayala Pharmaceuticals
AYLA
|
61.7 |
- |
- |
$ 7.46 M |
Israel |
 |
Aptorum Group Limited
APM
|
20.6 |
$ 1.33 |
-1.48 % |
$ 7.25 M |
China |
 |
Alterity Therapeutics Limited
ATHE
|
16.2 K |
$ 3.42 |
2.09 % |
$ 8.23 B |
Australia |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Amphastar Pharmaceuticals
AMPH
|
62.6 |
$ 25.9 |
0.74 % |
$ 1.25 B |
USA |
 |
Anika Therapeutics
ANIK
|
77.3 |
$ 9.49 |
- |
$ 139 M |
USA |
 |
Brickell Biotech
BBI
|
254 |
- |
-5.38 % |
$ 6.06 M |
USA |
 |
BeiGene, Ltd.
BGNE
|
49.5 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Bellicum Pharmaceuticals
BLCM
|
6.09 |
- |
-9.72 % |
$ 5.89 M |
USA |
 |
Berkeley Lights
BLI
|
103 |
- |
-7.31 % |
$ 87 M |
USA |
 |
Aytu BioScience
AYTU
|
150 |
$ 2.28 |
- |
$ 14.3 M |
USA |
 |
Arena Pharmaceuticals
ARNA
|
946 |
- |
-6.81 % |
$ 3.04 B |
USA |
 |
Biogen
BIIB
|
57.9 |
$ 172.5 |
- |
$ 25.1 B |
USA |
 |
Baudax Bio
BXRX
|
126 |
- |
0.59 % |
$ 63 K |
USA |
 |
Benitec Biopharma
BNTC
|
141 |
$ 12.96 |
1.17 % |
$ 533 M |
USA |
 |
ChromaDex Corporation
CDXC
|
13.2 |
- |
-0.88 % |
$ 598 M |
USA |
 |
Axon Enterprise
AXON
|
134 |
$ 581.03 |
2.22 % |
$ 44 B |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
28.1 |
$ 0.29 |
-0.31 % |
$ 631 M |
Israel |
 |
Checkpoint Therapeutics
CKPT
|
6.83 |
- |
- |
$ 169 M |
USA |
 |
Caladrius Biosciences
CLBS
|
164 |
- |
-16.75 % |
$ 25.8 M |
USA |
 |
Catalyst Biosciences
CBIO
|
3.24 |
$ 15.31 |
- |
$ 1.01 B |
USA |
 |
Clovis Oncology
CLVS
|
65.5 |
- |
-7.23 % |
$ 13 M |
USA |
 |
Cerus Corporation
CERS
|
59.2 |
$ 2.15 |
13.76 % |
$ 397 M |
USA |
 |
Celldex Therapeutics
CLDX
|
86.5 |
$ 27.94 |
- |
$ 1.8 M |
USA |
 |
Deciphera Pharmaceuticals
DCPH
|
60.8 |
- |
- |
$ 2.18 B |
USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
169 |
$ 11.44 |
7.92 % |
$ 740 M |
USA |
 |
Epizyme
EPZM
|
47.2 |
- |
- |
$ 249 M |
USA |